0001567619-20-006996.txt : 20200325 0001567619-20-006996.hdr.sgml : 20200325 20200325160940 ACCESSION NUMBER: 0001567619-20-006996 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200323 FILED AS OF DATE: 20200325 DATE AS OF CHANGE: 20200325 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Campoy Carlos CENTRAL INDEX KEY: 0001761518 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37587 FILM NUMBER: 20742270 MAIL ADDRESS: STREET 1: 11804 NORTH CREEK PARKWAY SOUTH CITY: BOTHELL STATE: WA ZIP: 98011 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CytomX Therapeutics, Inc. CENTRAL INDEX KEY: 0001501989 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 273521219 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 151 OYSTER POINT BLVD. STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650.515.3185 MAIL ADDRESS: STREET 1: 151 OYSTER POINT BLVD. STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc1.xml FORM 4 X0306 4 2020-03-23 0 0001501989 CytomX Therapeutics, Inc. CTMX 0001761518 Campoy Carlos C/O CYTOMX THERAPEUTICS, INC. 151 OYSTER POINT BLVD., STE. 400 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Financial Officer Stock Option (Right to Buy) 4.93 2020-03-23 4 A 0 350000 0.00 A 2030-03-22 Common Stock 350000 350000 D The shares subject to the Inducement Option Award will vest and become exercisable as to 25% of the total number of shares subject to the option on March 23, 2021 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. /s/ Lloyd Rowland, as Attorney-in-Fact for Carlos Campoy 2020-03-25